Aldeyra Therapeutics, Inc. (ALDX) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es EDELMAN JOSEPH con 11,350,085 acciones. Otros tenedores destacados incluyen PERCEPTIVE ADVISORS LLC y Brady Todd C.
En los últimos 12 meses, los internos han realizado 14 transacciones en ALDX acciones — 12 compras (valoradas en $338.28K) y 1 ventas (valoradas en $113.71K). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
ALDX Participación de Insiders
Principal Titular
EDELMAN JOSEPH
11,350,085 acciones
Compras (12 meses)
12
$338.28K valor
Ventas (12 meses)
1
$113.71K valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Edelman Joseph |
Director |
11,350,085 |
2022-08-11 |
|
| 2 |
Perceptive Advisors Llc |
10 Percent Owner |
5,875,851 |
2025-04-07 |
|
| 3 |
Brady Todd C |
President and CEO |
632,318 |
2026-03-31 |
|
| 4 |
Reed Joshua |
Chief Financial Officer |
250,000 |
2022-04-01 |
|
| 5 |
Mcmullin David |
Chief Commercial Officer |
250,000 |
2020-03-06 |
|
| 6 |
Machatha Stephen |
Chief Development Officer |
221,799 |
2025-08-13 |
|
| 7 |
Douglas Richard |
Director |
195,000 |
2026-03-20 |
|
| 8 |
Greenberg Bruce |
See Remarks |
126,382 |
2024-08-14 |
|
| 9 |
Clark William D |
Director |
76,760 |
2025-04-18 |
|
| 10 |
Clark David J |
Chief Medical Officer |
17,878 |
2019-09-10 |
|
| 11 |
Shah Nimesh |
10 Percent Owner |
10,358 |
2015-12-18 |
|
| 12 |
Domain Associates |
10 Percent Owner |
10,358 |
2014-05-01 |
|
| 13 |
Young Scott |
Chief Operating Officer |
10,000 |
2016-03-18 |
|
| 14 |
Alfieri Michael |
Principal Financial Officer |
7,500 |
2026-03-19 |
|
| 15 |
Clarke C. Boyd |
Director |
6,083 |
2016-06-10 |
|
| 16 |
Tulipano Stephen J |
Chief Financial Officer |
5,410 |
2018-03-08 |
|
| 17 |
Bronstein Ben |
Director |
3,860 |
2025-06-12 |
|
| 18 |
Phillips Gary M. |
Director |
3,619 |
2025-06-12 |
|
| 19 |
Miller-rich Nancy |
Director |
2,413 |
2025-06-12 |
|
| 20 |
Walker Neal |
Director |
2,413 |
2025-06-12 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-27 |
Brady Todd C |
President and CEO |
Concesión de RSU |
632,318 |
- |
- |
| 2026-03-19 |
Douglas Richard |
Director |
Compra Informativa |
70,000 |
$1.40 |
$98K |
| 2026-03-18 |
Alfieri Michael |
Principal Financial Officer |
Compra Informativa |
5,000 |
$1.42 |
$7.1K |
| 2025-08-13 |
Alfieri Michael |
Principal Financial Officer |
Compra Informativa |
2,500 |
$5.30 |
$13.25K |
| 2025-08-11 |
Machatha Stephen |
Chief Development Officer |
Venta Informativa |
22,073 |
$5.15 |
$113.71K |
| 2025-06-10 |
Miller-rich Nancy |
Director |
Concesión de RSU |
2,413 |
$2.69 |
$6.48K |
| 2025-06-10 |
Bronstein Ben |
Director |
Concesión de RSU |
3,619 |
$2.69 |
$9.72K |
| 2024-06-10 |
Bronstein Ben |
Director |
Concesión de RSU |
3,860 |
$2.69 |
$10.36K |
| 2025-06-10 |
Walker Neal |
Director |
Concesión de RSU |
2,413 |
$2.69 |
$6.48K |
| 2025-06-10 |
Joyce Martin Joseph |
Director |
Concesión de RSU |
1,689 |
$2.69 |
$4.53K |
| 2025-06-10 |
Phillips Gary M. |
Director |
Concesión de RSU |
3,619 |
$2.69 |
$9.72K |
| 2025-06-10 |
Douglas Richard |
Director |
Concesión de RSU |
1,689 |
$2.69 |
$4.53K |
| 2025-04-17 |
Clark William D |
Director |
Concesión de RSU |
76,760 |
$2.19 |
$168.1K |
| 2025-04-17 |
Clark William D |
Officer |
Desconocido |
- |
- |
- |
